№ files_lp_3_process_7_086960
File format: docx
Character count: 6008
File size: 21 KB
Official position description outlining duties, qualifications, reporting structure, and operational responsibilities for a state-level public health consultant role focused on prescription drug overdose prevention under a federally funded initiative.
Organization:
Michigan Public Health Institute
Division:
MDHHS Division of Chronic Disease and Injury Control
Program:
MDHHS Prescription Drug Overdose: Data-Driven Prevention Initiative (PDO: DDPI)
Supervisor:
Jennifer DeLaCruz
Location:
Lansing area, Michigan
Funding Source:
Centers for Disease Control and Prevention grant
Position Type:
Exempt under the Fair Labor Standards Act
Primary Focus:
Prescription opioid and heroin overdose primary prevention
Key Responsibilities:
Program development, contract monitoring, grant reporting, budget oversight, stakeholder coordination, technical assistance
Education Requirement:
Master’s degree in public health, social work, or closely related health field
Experience Requirement:
Minimum one year experience in substance use disorder, health education, outreach, or project management
Collaborating Agencies:
Michigan Department of Health and Human Services; Department of Licensing and Regulatory Affairs
Work Requirements:
Significant travel; valid driver’s license; extensive computer use
Reporting Obligations:
Federal performance and financial reporting
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
Richmond, VA
Topic:
Opioid overdose, Naloxone
Document Type:
Instructional Guide
Organization:
Virginia Department of Behavioral Health and Developmental Services
Author:
N/A
Target Audience:
General public, individuals attending REVIVE! training
Effective Date:
N/A
Date of Last Revision:
September 2021
Year:
2025
Note:
Region / City
Topic:
Overdose Case Definitions
Document Type:
Guideline
Organization:
NEMSIS
Target Audience:
EMS Providers, Medical Personnel
Note:
Year
Theme:
Overdose Recognition, Naloxone, Opioid Epidemic
Document Type:
Training Material
Target Audience:
Community Health Workers/Representatives, CHW/R Managers, College/University Students, Community Leaders
Version:
April 24, 2024
Year:
2024
Region / City:
Ohio
Theme:
Emergency Department Overdose Reporting
Document Type:
Compliance Effort
Organization / Institution:
CliniSync, Ohio Department of Health
Author:
Phil Ennen
Target Audience:
Health Systems, Hospitals, Stakeholders in Ohio
Effective Date:
April 8, 2024
Date of Approval:
March 25, 2024
Date of Last Change:
February 2024
Year:
2022
Region / City:
United States
Topic:
Opioid overdose prevention, data collection, and evaluation
Document type:
Evaluation plan
Agency / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
State and local health departments, program implementers, stakeholders in overdose prevention
Period of validity:
2022–2026
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
Not specified
Region / City:
Not specified
Document Type:
Research Table
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, researchers
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
New Jersey
Subject:
Substance Use Disorders, Law Enforcement, Recovery Support
Document Type:
Public Notice
Institution:
Department of Law and Public Safety
Author:
Office of the Attorney General
Target Audience:
County Prosecutors, Law Enforcement, Recovery Specialists, Healthcare Partners
Period of Effectiveness:
September 1, 2021 - August 31, 2022
Approval Date:
N/A
Amendment Date:
N/A
Year:
2021
Region / City:
Kansas
Topic:
Overdose Fatality Review, Substance Use, Public Health
Document Type:
Meeting Minutes
Organization / Institution:
Kansas Department of Health and Environment (KDHE)
Author:
Ryan Lester, Adrienne Hearrell, Jennifer Donnelly, Julia Baughman, Krista Machado
Target Audience:
Public health professionals, healthcare providers, policy makers
Validity Period:
2021
Approval Date:
July 6, 2021
Modification Date:
Not mentioned
Year:
2020
Region / City:
United States
Topic:
Overdose Surveillance
Document Type:
Plan
Organization / Institution:
CDC
Author:
Centers for Disease Control and Prevention
Target Audience:
State and local governments, non-governmental organizations, healthcare providers, community-based organizations
Period of Validity:
Until completion of dissemination activities
Approval Date:
August 31, 2020
Revision Date:
None
Organization:
Centers for Disease Control and Prevention
Program:
Enhanced State Opioid Overdose Surveillance (ESOOS)
Version:
v1
Subject:
Opioid overdose syndrome definition
Document type:
Public health surveillance guidance
Scope:
Emergency department visit monitoring
Data sources:
ICD-9-CM, ICD-10-CM, SNOMED, chief complaint free text
Related organizations:
National Center for Health Statistics; Council of State and Territorial Epidemiologists; Substance Abuse and Mental Health Services Administration
Intended users:
ESOOS-funded state health departments
Geographic coverage:
United States
Limitations:
Cannot differentiate prescription from illicit opioid overdose; cannot distinguish fentanyl from fentanyl analogs
Year:
2024
Region / City:
Massachusetts
Topic:
Opioid Overdose Rescue and Prevention
Document Type:
Training Guide
Organization / Institution:
Health Resources in Action (HRiA), Massachusetts Department of Public Health
Author:
BeHERE Initiative
Target Audience:
Trainers and participants in overdose prevention training
Duration:
120 minutes
Approval Date:
April 2024
Date of Last Update:
April 2024
Year:
2027
Region / Jurisdiction:
Maryland
Document Type:
Grant Program Application Form
Program:
Competitive Grant Program
Issuing Office:
Maryland’s Office of Overdose Response (MOOR)
Subject Area:
Overdose prevention, substance use disorder services, and public health initiatives
Strategic Priorities:
Prevention; Drug User Health; Treatment; Recovery; Public Safety
Eligible Project Areas:
Social determinants of health; adverse childhood experiences and trauma; evidence-based prevention; low-threshold services; risk reduction tools; overdose education and naloxone distribution; medications for opioid use disorder; barrier reduction in care; holistic care for people who use drugs; employment and recovery supports; community-based recovery; criminal justice health impact reduction; reentry service connections
Application Components:
Project Summary; Problem Statement; Program Measurement and Performance Indicators; Timeline; Budget Detail and Narrative; Program Sustainability Plan
Applicant Information Required:
Organization name, FEIN, point of contact, position, phone, email
Certification Requirement:
Applicant signature and confirmation of accuracy of submitted information
Administering Authority:
Maryland’s Office of Overdose Response
Year:
2026
Region / City:
Global
Subject:
Emergency treatment of opioid overdose
Document Type:
Pharmaceutical product monograph
Organization / Institution:
OPVEE™ Pharmaceuticals
Author:
OPVEE™ Research and Development Team
Target Audience:
Healthcare professionals and emergency responders
Dosage Form:
Nasal spray
Active Ingredient:
Nalmefene hydrochloride
Indications:
Treatment of known or suspected opioid overdose in patients 12 years and older
Pharmacokinetics:
Nasal administration, onset 2.5–5 minutes, duration ~6 hours above EC50
Safety Considerations:
Pregnancy, lactation, pediatric and geriatric usage, renal and hepatic impairment
Contraindications:
Hypersensitivity to nalmefene or other components
Adverse Effects:
Possible acute withdrawal in opioid-dependent patients, recurrence of respiratory depression
Note:
Year
Topic:
Produce Prescription Program, Community-Based Partnerships
Document Type:
Memorandum of Understanding (MOU)
Target Audience:
Community-based organizations, healthcare providers, clinics
Context:
Template for establishing a formal partnership agreement between a community-based organization and a clinic to implement a produce prescription program.
Year:
2026
Region / City:
Hamstreet
Theme:
Healthcare, Dispensary Services
Document Type:
Informational Announcement
Organization / Institution:
Hamstreet Dispensary
Author:
Hamstreet Dispensary
Target Audience:
Patients of Hamstreet Dispensary
Effective Period:
From January 2026
Approval Date:
January 2026
Modification Date:
Not specified
Year:
2019
Region / City:
United States
Topic:
Information Technology, Veterans Affairs, Healthcare
Document Type:
Performance Work Statement
Agency / Institution:
Department of Veterans Affairs, Office of Information & Technology
Author:
Not specified
Target Audience:
Contractors, VA staff, IT professionals
Period of Effectiveness:
June 27, 2019, onwards
Approval Date:
June 27, 2019
Amendments Date:
Not specified
Year:
2015
Region / City:
Chicago
Theme:
Health insurance, public sector
Document type:
Request for Proposal (RFP)
Organ / Institution:
City of Chicago, Chicago Park District, Chicago Public Schools
Author:
City of Chicago Department of Finance
Target audience:
Organizations with experience in HMO and/or Prescription Drug solutions
Period of validity:
January 1, 2016 - (contract term)
Approval date:
Not specified
Amendment date:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2024
Region / City:
Ireland
Topic:
Healthcare, Rehabilitation, Trauma
Document Type:
Rehabilitation Guideline
Organization:
Health Service Executive (HSE)
Author:
National Office for Trauma Services
Target Audience:
Healthcare professionals in the trauma care system
Period of validity:
September 2024 - September 2025
Approval Date:
September 2024
Revision Date:
September 2025
Responsibility for Review and Audit:
Trauma System Implementation Programme
Year:
2026
Region / City:
United States
Theme:
Prescription Drug Plans, Medicare
Document Type:
Instruction Manual
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
CMS
Target Audience:
Prescription Drug Plan Sponsors, Medicare Advantage Organizations
Period of Validity:
Contract Year 2026
Approval Date:
December 13, 2024
Date of Modifications:
Not specified